ORIENTBIO Inc
002630
Company Profile
Business description
ORIENTBIO Inc is engaged in research and development in biotechnology. It manufactures biological materials and bio experiment apparatus. It also provides research models such as rabbits and mice, contract research organization (CRO) services and solutions for biomedical research.
Contact
322 Galmachi-ro
Jungwon-gu
SeongnamGyeonggi
KORT: +82 317306000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
123
Stocks News & Analysis
stocks
Netflix: A business that’s nearly flawless
Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks
Trump’s US dollar assault is fuelling CBA’s rise
A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks
Insignia Financial: Revised deal still attractive
The offer price is well above our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,979.40 | 22.00 | -0.24% |
| CAC 40 | 7,813.97 | 36.46 | -0.46% |
| DAX 40 | 24,292.55 | 51.73 | 0.21% |
| Dow JONES (US) | 44,766.33 | 243.96 | -0.54% |
| FTSE 100 | 9,144.95 | 83.46 | 0.92% |
| HKSE | 25,667.18 | 129.11 | 0.51% |
| NASDAQ | 21,059.31 | 39.29 | 0.19% |
| Nikkei 225 | 41,826.34 | 655.02 | 1.59% |
| NZX 50 Index | 12,805.13 | 11.07 | 0.09% |
| S&P 500 | 6,367.96 | 9.05 | 0.14% |
| S&P/ASX 200 | 8,709.40 | 27.80 | -0.32% |
| SSE Composite Index | 3,605.73 | 23.43 | 0.65% |